From ‘Make in India’ to ‘Made in India’: The saroglitazar story

oleh: Sivasubramanian Ramakrishnan, MD, DM, FACC

Format: Article
Diterbitkan: Elsevier 2015-01-01

Deskripsi

Subjek

Saroglitazar; PPAR agonists; Indian pharmaceutical industry; Made in India